Pharvaris Management
Management criteria checks 3/4
Pharvaris' CEO is Berndt Axel Modig, appointed in Sep 2015, has a tenure of 8.58 years. total yearly compensation is €532.00K, comprised of 100% salary and 0% bonuses, including company stock and options. directly owns 2.23% of the company’s shares, worth $26.28M. The average tenure of the management team and the board of directors is 2.3 years and 3.3 years respectively.
Key information
Berndt Axel Modig
Chief executive officer
€532.0k
Total compensation
CEO salary percentage | 100.0% |
CEO tenure | 8.6yrs |
CEO ownership | 2.2% |
Management average tenure | 2.3yrs |
Board average tenure | 3.3yrs |
Recent management updates
Recent updates
Pharvaris: Digging Deep For Sufficient Market Size
Jan 17We Think Pharvaris (NASDAQ:PHVS) Can Afford To Drive Business Growth
Oct 09Pharvaris (NASDAQ:PHVS) Is In A Good Position To Deliver On Growth Plans
May 13Companies Like Pharvaris (NASDAQ:PHVS) Are In A Position To Invest In Growth
Jan 11We Think Pharvaris (NASDAQ:PHVS) Can Afford To Drive Business Growth
Sep 26Pharvaris GAAP EPS of -€0.38
Sep 12Pharvaris slips 19% after FDA clinical hold on hereditary angioedema candidate
Aug 22We're Not Very Worried About Pharvaris' (NASDAQ:PHVS) Cash Burn Rate
Jun 08Pharvaris (NASDAQ:PHVS) Is In A Good Position To Deliver On Growth Plans
Dec 21We're Not Very Worried About Pharvaris' (NASDAQ:PHVS) Cash Burn Rate
Aug 25Pharvaris reports Q1 results
May 26CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Dec 31 2023 | €532k | €532k | -€101m |
Sep 30 2023 | n/a | n/a | -€107m |
Jun 30 2023 | n/a | n/a | -€92m |
Mar 31 2023 | n/a | n/a | -€83m |
Dec 31 2022 | €500k | €500k | -€76m |
Sep 30 2022 | n/a | n/a | -€49m |
Jun 30 2022 | n/a | n/a | -€50m |
Mar 31 2022 | n/a | n/a | -€53m |
Dec 31 2021 | €414k | €414k | -€43m |
Sep 30 2021 | n/a | n/a | -€41m |
Jun 30 2021 | n/a | n/a | -€38m |
Mar 31 2021 | n/a | n/a | -€29m |
Dec 31 2020 | €404k | €404k | -€26m |
Compensation vs Market: Berndt Axel's total compensation ($USD565.30K) is below average for companies of similar size in the US market ($USD3.45M).
Compensation vs Earnings: Berndt Axel's compensation has increased whilst the company is unprofitable.
CEO
Berndt Axel Modig (64 yo)
8.6yrs
Tenure
€532,000
Compensation
Mr. Berndt Axel Edvard Modig, MBA, CPA, serves as Chief Executive Officer since 2015 and Executive Director of Pharvaris B.V. Mr. Modig served as a Member of the Supervisory Board at Centogene N.V. since A...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Co-Founder | 8.6yrs | €532.00k | 2.23% € 26.3m | |
Head of Strategic Finance & Principal Accounting Officer | no data | no data | 0.0037% € 43.4k | |
Chief Technology Operations Officer | less than a year | no data | no data | |
Chief Legal Officer | 1.8yrs | no data | 0.010% € 121.7k | |
Chief Human Resources Officer | 1.6yrs | no data | no data | |
Chief Medical Officer | 4.2yrs | no data | 0.063% € 744.6k | |
Chief Early Development Officer | no data | no data | 0.46% € 5.5m | |
Chief Business Officer | no data | no data | 0.026% € 311.9k | |
Chief Community Engagement & Commercial Officer | 2.8yrs | no data | 0% € 0 | |
Director of Corporate Relations | no data | no data | no data |
2.3yrs
Average Tenure
53yo
Average Age
Experienced Management: PHVS's management team is considered experienced (2.3 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Co-Founder | no data | €532.00k | 2.23% € 26.3m | |
Independent Non-Executive Director | 3.3yrs | €50.50k | 0% € 0 | |
Independent Non-Executive Chair | 3.3yrs | €94.00k | 0.093% € 1.1m | |
Independent Vice Chairman | 4.7yrs | €61.00k | 0.93% € 11.0m | |
Non-Executive Director | 2.3yrs | €45.00k | 0% € 0 | |
Non-Executive Director | 2.8yrs | €62.50k | 0% € 0 |
3.3yrs
Average Tenure
63yo
Average Age
Experienced Board: PHVS's board of directors are considered experienced (3.3 years average tenure).